Hengkang Medical Group Co Ltd
SZSE:002219

Watchlist Manager
Hengkang Medical Group Co Ltd Logo
Hengkang Medical Group Co Ltd
SZSE:002219
Watchlist
Price: 2.31 CNY -1.28% Market Closed
Market Cap: ¥7.8B

P/FCFE

45.3
Current
152%
More Expensive
vs 3-y average of 18

Price to Free Cash Flow to Equity (P/FCFE) ratio compares a company`s market value to the free cash flow available to its shareholders. It`s similar to the P/OCF ratio but more precise, since it accounts for capital expenditures deducted from operating cash flow.

P/FCFE
45.3
=
Market Cap
¥8.4B
/
Free Cash Flow to Equity
¥172.8m

Price to Free Cash Flow to Equity (P/FCFE) ratio compares a company`s market value to the free cash flow available to its shareholders. It`s similar to the P/OCF ratio but more precise, since it accounts for capital expenditures deducted from operating cash flow.

P/FCFE
45.3
=
Market Cap
¥8.4B
/
Free Cash Flow to Equity
¥172.8m

Valuation Scenarios

Hengkang Medical Group Co Ltd is trading above its 3-year average

If P/FCFE returns to its 3-Year Average (18), the stock would be worth ¥0.92 (60% downside from current price).

Statistics
Positive Scenarios
0/4
Maximum Downside
-69%
Maximum Upside
No Upside Scenarios
Average Downside
50%
Scenario P/FCFE Value Implied Price Upside/Downside
Current Multiple 45.3 ¥2.31
0%
3-Year Average 18 ¥0.92
-60%
5-Year Average 14 ¥0.72
-69%
Industry Average 31.4 ¥1.6
-31%
Country Average 26.4 ¥1.35
-42%

Forward P/FCFE
Today’s price vs future free cash flow to equity

Not enough data available to calculate forward P/FCFE

Peer Comparison

All Multiples
P/FCFE
P/E
All Countries
Close

Market Distribution

In line with most companies in China
Percentile
66th
Based on 5 086 companies
66th percentile
45.3
Low
0.2 — 13.7
Typical Range
13.7 — 52.8
High
52.8 —
Distribution Statistics
China
Min 0.2
30th Percentile 13.7
Median 26.4
70th Percentile 52.8
Max 2 279 450.9

Hengkang Medical Group Co Ltd
Glance View

Market Cap
7.8B CNY
Industry
Health Care

Hengkang Medical Group Co Ltd. stands as a testament to the burgeoning evolution of healthcare in China. Founded with a vision to modernize traditional healthcare systems, the company has woven an intricate network of hospitals and healthcare services across the country, tapping into the ever-growing demand for quality medical care. At the heart of Hengkang's operations is its commitment to providing comprehensive medical services—from outpatient and inpatient care to specialized treatments—all under one roof. This vertically integrated approach not only ensures seamless delivery of care but also drives efficiencies through economies of scale. By investing in advanced medical technologies and skilled professionals, Hengkang positions itself as a leader in the healthcare landscape, providing services that cater to diverse medical needs, thereby consistently drawing a steady stream of patients and insurance collaborations. What sets Hengkang apart is its keen focus on aligning healthcare delivery with digital transformation. The company leverages digital platforms to streamline its operations, enhance patient experiences, and optimize resource allocation. This digital shift plays a crucial role in its revenue model—Hengkang taps into data analytics to provide value-added services, optimize operational workflows, and predict healthcare trends, which not only improve patient outcomes but also drive profitability. Furthermore, its portfolio extends beyond clinical care; the group actively engages in partnering with biotech research initiatives and health management programs, broadening its reach and reinforcing its market position as an integrated healthcare service provider. This multifaceted strategy ensures Hengkang's resilience and adaptability in an ever-changing industry, catalyzing its growth and solidifying its reputation as a beacon of modern healthcare.

Intrinsic Value
1.74 CNY
Overvaluation 25%
Intrinsic Value
Price ¥2.31
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett